Tag: China

Sinovant Sciences unveiled its drug pipeline

good laboratory practice
Sinovant Sciences, a Shanghai-based biopharmaceutical company dedicated to bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad, unveiled its pipeline and leadership team.

China will bring down prices for cancer drugs

china street
China's state medical insurance administration will start a new round of negotiations with pharmaceutical companies to add more cancer drugs to the insurance list.

Sanofi sets up its Global R&D Operations Hub in China

sanofi-china
Sanofi is launching a Global R&D Operations Hub with a specialized focus on digitalization and big data analysis in Chengdu, Sichuan province, China.

CASI Pharmaceuticals partnered with Yiling Wanzhou International Pharmaceutical

drug development
CASI Pharmaceuticals, a US-based biopharmaceutical company, will expand its presence in China by entering into a long-term manufacturing agreement with China’s Yiling Wanzhou International Pharmaceutical Co. Ltd

Johnson & Johnson Institute opened a new facility in China

johnsonandjohnson
The Johnson & Johnson Institute, a leader in professional medical education, announced the opening of its new facility in Beijing. It represents the largest investment in the global relaunch of the Johnson & Johnson institutes.

Russian equipment for storage of thermolabile drugs was delivered to China

pozis
POZIS JSC, an affiliate of Techmash concern of Rostec Corporation, for the first time delivered Russian medical equipment to Hong Kong.

China will conduct regulatory trainings for Indian pharma companies

china street
China has agreed to conduct specific training programmes for Indian pharmaceutical companies to understand their regulatory system, which will promote India's exports from the sector.

China Food and Drug Administration approved a new HIV drug

hiv
China Food and Drug Administration (FDA) has approved the sale of a new drug for the treatment of HIV-1 infection, the maker of the drug said.

China’s domestic pharma industry driving huge machinery influx at P-MEC China

45,000 industry experts attend as intelligent manufacturing and new environmental policies identified as key medium term trends

Novel medicines development company Brii Bio launches in China

drug development
Brii Bio, a Chinese company committed to serving patients’ needs and improving public health, announced its launch with significant partnerships and financing.

WuXi Biologics to establish a biologics development and manufacturing center

drug-development
WuXi Biologics, a leading global open-access biologics technology platform company, announced that it is to build an integrated biologics development, clinical and commercial manufacturing center in Northern China.

Top pharma players place their stakes on Chinese market

china street
Pharmaceutical giant Bayer reported a robust growth in its pharmaceutical business in China, as its total sales stood at 17 billion yuan ($2.67 billion) in 2017, a year-on-year growth of 18.3 percent.

WuXi STA will set up a new R&D Center

biotechnology
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), signed an investment agreement with the government of Shanghai Jinshan District to build a new R&D center.

China stimulates the research and development of generics

generics
With support in research and development, registration of Chinese generic drugs and marketing of the drugs in the global market, companies will be encouraged by the government to carry out international cooperation.

Chinese CDMO receives funding to expand GMP manufacturing capabilities

manufacturing
CMAB Biopharma, a Chinese full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic products, raised $34 million fin...

United BioPharma begin to build a new biopharmaceutical manufacturing plant

biotechnologies
United BioPharma (UBP), a Chinese clinical stage biotech company, announced the beginning of construction of a state-of-the-art biopharmaceutical manufacturing plant in China.